Taff Jones

Summary

Affiliation: MedImmune Vaccines
Country: USA

Publications

  1. ncbi Vacc-4x, a therapeutic vaccine comprised of four engineered peptides for the potential treatment of HIV infection
    Taff Jones
    MedImmune, 297 North Bernardo Avenue, Mountain View, CA 94043, USA
    Curr Opin Investig Drugs 11:964-70. 2010
  2. ncbi IMVAMUNE, an attenuated modified vaccinia Ankara virus vaccine for smallpox infection
    Taff Jones
    MedImmune Inc, 297 N Bernardo Ave, Mountain View, CA 94043, USA
    Curr Opin Mol Ther 10:407-17. 2008
  3. ncbi IC-51, an injectable vaccine for the prevention of Japanese encephalitis virus infection
    Taff Jones
    Clinical Testing Laboratories, MedImmune, 297 N Bernardo Avenue, Mountain View, CA 94043, USA
    Curr Opin Mol Ther 11:90-6. 2009
  4. ncbi GSK's novel split-virus adjuvanted vaccines for the prevention of the H5N1 strain of avian influenza infection
    Taff Jones
    MedImmune, Clinical Testing Laboratories, Mountain View, CA 94043, USA
    Curr Opin Mol Ther 11:337-45. 2009
  5. pmc Safety and immunogenicity following administration of a live, attenuated monovalent 2009 H1N1 influenza vaccine to children and adults in two randomized controlled trials
    Raburn M Mallory
    MedImmune, LLC, Gaithersburg, Maryland, United States of America
    PLoS ONE 5:e13755. 2010
  6. ncbi Remune. Immune Response
    Derhsing Lai
    Vincogen Corp, Yardley, PA 19067, USA
    Curr Opin Investig Drugs 3:391-8. 2002
  7. ncbi A chimeric live attenuated vaccine against Japanese encephalitis
    Taff Jones
    ID Biomedical Corp of Quebec, 7150 Frederick Banting, Montreal H4S 2A1, Quebec, Canada
    Expert Rev Vaccines 3:243-8. 2004

Collaborators

Detail Information

Publications7

  1. ncbi Vacc-4x, a therapeutic vaccine comprised of four engineered peptides for the potential treatment of HIV infection
    Taff Jones
    MedImmune, 297 North Bernardo Avenue, Mountain View, CA 94043, USA
    Curr Opin Investig Drugs 11:964-70. 2010
    ..If Vacc-4x vaccinees demonstrate significantly better responses than the placebo group in this trial, the prospects for Vacc-4x could be highly promising...
  2. ncbi IMVAMUNE, an attenuated modified vaccinia Ankara virus vaccine for smallpox infection
    Taff Jones
    MedImmune Inc, 297 N Bernardo Ave, Mountain View, CA 94043, USA
    Curr Opin Mol Ther 10:407-17. 2008
    ..Additional phase II trials were ongoing in these groups at the time of publication and phase III trials were planned for 2009...
  3. ncbi IC-51, an injectable vaccine for the prevention of Japanese encephalitis virus infection
    Taff Jones
    Clinical Testing Laboratories, MedImmune, 297 N Bernardo Avenue, Mountain View, CA 94043, USA
    Curr Opin Mol Ther 11:90-6. 2009
    ..The results suggests that IC-51 is fully compliant with the stringent regulatory requirements set by the WHO, has an acceptable safety profile and is non-inferior to JE-VAX...
  4. ncbi GSK's novel split-virus adjuvanted vaccines for the prevention of the H5N1 strain of avian influenza infection
    Taff Jones
    MedImmune, Clinical Testing Laboratories, Mountain View, CA 94043, USA
    Curr Opin Mol Ther 11:337-45. 2009
    ..With the enormous demand for an effective vaccine in the event of an H5N1 pandemic, GSK's inactivated split H5N1 virus vaccine likely will be a highly valued product...
  5. pmc Safety and immunogenicity following administration of a live, attenuated monovalent 2009 H1N1 influenza vaccine to children and adults in two randomized controlled trials
    Raburn M Mallory
    MedImmune, LLC, Gaithersburg, Maryland, United States of America
    PLoS ONE 5:e13755. 2010
    ..The safety, tolerability, and immunogenicity of a monovalent intranasal 2009 A/H1N1 live attenuated influenza vaccine (LAIV) were evaluated in children and adults...
  6. ncbi Remune. Immune Response
    Derhsing Lai
    Vincogen Corp, Yardley, PA 19067, USA
    Curr Opin Investig Drugs 3:391-8. 2002
    ..Analysts at Lehman Brothers predicted in September 2001, that the product would be launched onto the market with sales of US$150 million in 2004...
  7. ncbi A chimeric live attenuated vaccine against Japanese encephalitis
    Taff Jones
    ID Biomedical Corp of Quebec, 7150 Frederick Banting, Montreal H4S 2A1, Quebec, Canada
    Expert Rev Vaccines 3:243-8. 2004
    ..It therefore appears to be a cost-effective prophylactic vaccine against this debilitating disease...